Next Article in Journal
Penaeid Shrimp Chromosome Studies Entering the Post-Genomic Era
Next Article in Special Issue
Transcription Factor SATB2 Regulates Skeletal Muscle Cell Proliferation and Migration via HDAC4 in Pigs
Previous Article in Journal
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
Previous Article in Special Issue
Genome-Wide Detection of Copy Number Variations Associated with Miniature Features in Horses
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 14
Issue 11
10.3390/genes14112049
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Uncoupling Protein 3 Promotes the Myogenic Differentiation of Type IIb Myotubes in C2C12 Cells

by
Ziwei You
1,
Jieyu Wang
1,
Faliang Li
1,
Wei Hei
1,
Meng Li
1,
Xiaohong Guo
1,
Pengfei Gao
1,
Guoqing Cao
1,
Chunbo Cai
1,2,* and
Bugao Li
1,*
1
College of Animal Science, Shanxi Agricultural University, 1 Mingxian Nanlu, Jinzhong 030801, China
2
Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China
*
Authors to whom correspondence should be addressed.
Genes 2023, 14(11), 2049; https://doi.org/10.3390/genes14112049
Submission received: 8 October 2023 / Revised: 30 October 2023 / Accepted: 4 November 2023 / Published: 7 November 2023
(This article belongs to the Special Issue Functional Genomics, Genetics Breeding and Improvement of Domestic Animals)
Browse Figures
Versions Notes

Abstract

:
Uncoupling protein 3 (Ucp3) is an important transporter within mitochondria and is mainly expressed in skeletal muscle, brown adipose tissue and the myocardium. However, the effects of Ucp3 on myogenic differentiation are still unclear. This study evaluated the effects of Ucp3 on myogenic differentiation, myofiber type and energy metabolism in C2C12 cells. Gain- and loss-of-function studies revealed that Ucp3 could increase the number of myotubes and promote the myogenic differentiation of C2C12 cells. Furthermore, Ucp3 promoted the expression of the type IIb myofiber marker gene myosin heavy chain 4 (Myh4) and decreased the expression of the type I myofiber marker gene myosin heavy chain 7 (Myh7). In addition, energy metabolism related to the expression of PPARG coactivator 1 alpha (Pgc1-α), ATP synthase, H+ transportation, mitochondrial F1 complex, alpha subunit 1 (Atp5a1), lactate dehydrogenase A (Ldha) and lactate dehydrogenase B (Ldhb) increased with Ucp3 overexpression. Ucp3 could promote the myogenic differentiation of type IIb myotubes and accelerate energy metabolism in C2C12 cells. This study can provide the theoretical basis for understanding the role of Ucp3 in energy metabolism.

1. Introduction

Skeletal muscle plays an important role in maintaining body movement and energy homeostasis. Myofiber is the basic unit of skeletal muscle, which can be divided into four types according to the isomer of myosin heavy chain (Myhc). Myosin heavy chain 7 (Myh7), myosin heavy chain 2 (Myh2), myosin heavy chain 4 (Myh4), and myosin heavy chain 1 (Myh1) are the marker genes of type Ι, type ΙΙa, type ΙΙb and type ΙΙx myofibers, respectively [1]. Different myofibers can be transformed into other myofibers [2]. The mitochondrial activity and oxidative metabolism vary in the four types of myofibers. Type Ι myofibers contain a large amount of mitochondria and cytochrome, which promote oxidative metabolism, while the type ΙΙb myofibers are the opposite. The characteristics of type ΙΙa and ΙΙx myofibers are between type Ι and ΙΙb myofibers [3]. The contents of the four types of myofibers are correlated with meat quality. The higher the content of type Ι myofibers, the better the meat quality. Therefore the transformation between different types of myofibers becomes very important in improving meat quality [4].
Uncoupling protein 3 (Ucp3) is an anionic carrier protein located in the inner membrane of mitochondria [5], which is mainly expressed in the skeletal muscles. Ucp3 is expressed more in glycolysis muscle fibers than in oxidized muscle fibers [6]. So far, Ucp3 has mainly been focused on in the research on lipid oxidative metabolism and mitochondrial reactive oxygen species. Ucp3 can promote the transformation of porcine white adipose cells into beige adipose cells, which can promote heat production by increasing the rate of respiratory oxygen consumption in adipose cells [7]. Cai et al. found that the content of subcutaneous fat in MSTN−/− Meishan pigs decreased when the expression of Ucp3 was significantly increased [8]. Bezaire et al. found that the skeletal-muscle-specific overexpression of Ucp3 mice had stronger fatty acid uptake and oxidation capacity compared with wild-type mice [9]. Similarly, MacLellan et al. indicated that the expression of Ucp3 and fatty acid content in rat myoblast cells (L6) increased [10]. Ucp3 can also protect mitochondria from damage caused by oxidative stress [11,12]. However, there are few reports about the effect of Ucp3 on myogenic differentiation, and its function is still unclear.
The present research aimed to explore the regulation of Ucp3 on the myogenic differentiation, myofiber transformation and energy metabolism of C2C12 cells using immunofluorescence staining and a quantitative real-time polymerase link reaction. It provides a theoretical basis for the study of the molecular mechanism of skeletal muscle cell metabolism.

2. Materials and Methods

2.1. C2C12 Cells Culture and Myogenic Differentiation

The C2C12 cells were purchased from Shanghai Jianing Biotechnology Company. Resuscitated cells were cultured in dishes supplemented with 7 mL of complete medium containing 10% fetal bovine serum (FBS; Gibco, Grand Island, NE, USA, Cat. 10099141). When the cell density reached about 75%, the cells were digested with trypsin (Gibco, Grand Island, NE, USA, Cat. 25200072) and divided into 6-well plates for 24 h of culture. When the cell density reached about 50%, an appropriate amount of lentivirus-packed vectors was added to the serum-free culture medium (Opti-MEM; Gibco, Grand Island, NE, USA, Cat. 31985070) to infect the cells and then cultured for 12 h. Then, the transfected medium was replaced with a complete growth medium (high-glucose DMEM, 10% FBS and 1% penicillin streptomycin) and continued to be cultured for 24 h. When the cells converged to 85%, the transfected C2C12 cells were treated with a culture medium containing 2% horse serum (Gibco, Grand Island, NE, USA, Cat. 16050122) to induce myogenic differentiation. The culture medium was changed every 2 days.

2.2. RNA Extraction and cDNA Synthesis

Total RNA was extracted from C2C12 cells using Trizol reagent (Takara, Kusatsu, Japan, Cat. 9108) according to the manufacturer’s instructions. Thereafter, 1 μg of total RNA was reverse transcribed with the PrimeScript Regent Kit with gDNA Eraser (Takara, Kusatsu, Japan, Cat. RR047A) using random hexamer primers according to the manufacturer’s instructions. The total system of the reaction was 20 microliters and was gently mixed and incubated at 50 °C for 5 min and heated at 85 °C for 2 min.

2.3. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)

Real-time PCR was performed with an Applied Biosystems Quant Studio 3 Real-time PCR System (Thermo Fisher Scientific, Waltham, MA, USA). Quantitative real-time PCR was performed using TB Green Premix Ex Taq II (Takara, Kusatsu, Japan, Cat. RR820A). The expressions of all coding genes were normalized to 18S rRNA. The “2−ΔΔCt” formula was used to estimate the mean of the triplicate cycle thresholds (CTs) to obtain the relative expression levels. Gene-specific primers were designed using the online website Primer 3 (http://bioinfo.ut.ee/primer3-0.4.0/ (accessed on 10 August 2023)) and synthesized by Shanghai Shenggong Biotech Co., Ltd. (Shanghai, China). The reaction system was 10 μL and comprised the following: 5 μL SYBR, 4 μL cDNA, and 0.5 μL each for upstream and downstream primers. The reaction procedure was as follows: predenaturated at 95 °C for 30 min, denatured at 94 °C for 10 s, annealed at 60 °C for 20 s, extended at 72 °C for 30 s and carried out for 40 cycles. The primer sequences used for the qRT-PCR analyses are listed in Table 1.

2.4. Lentiviral-Mediated Transduction

A pair of short hairpin oligonucleotides (GAAGAGGGCCTTAATGAAAG) targeting the open reading frame (ORF) of Ucp3 were designed and synthesized using GenePharma. Both the vector construction and lentivirus package were undertaken using Gene Pharma. The C2C12 cells were cultured in 6-well plates. When the cell density was about 50%, the appropriate amount of lentivirus was directly added to the medium for infection. The culture medium was changed to a fresh medium after 24 h of infection.

2.5. Immunofluorescence Staining

After myogenic differentiation for 6 days in C2C12 cells, a large number of myotubes could be observed and immunofluorescence staining was performed. The cells were washed with PBS three times, fixed with 4% paraformaldehyde for 30 min and then cleaned with PBS three times. The cells were permeated using 0.5% Triton X-100 at room temperature for 20 min and sealed with 2% goat serum for 1 h. The cells were then treated with primary antibody and incubated overnight at 4 °C. The information regarding the primary antibody is as follows: anti-Myosin Heavy Chain mouse monoclonal antibody (Myhc, Iowa City, IA, USA, Cat. MF20, 1:100), anti-Myosin Heavy Chain 4 mouse monoclonal antibody (Myh4, Iowa City, IA, USA, Cat. BF-F3, 1:100) and anti-Myosin Heavy Chain 7 mouse monoclonal antibody (Myh7, Iowa City, IA, USA, Cat. BA-D5, 1:100). After incubation with the primary antibody, the cells were washed three times in PBS with 0.025% Tween20 and then incubated with an appropriate fluorescent secondary Goat anti-mouse lgG (H+L) Alexa594 antibody (Chicago, IL, USA, Cat. SA00013-3, 1:100) for 1 h at room temperature. Then, the nuclei were labeled with DAPI. Finally, the cells were washed three times with PBS and observed under a fluorescence microscope (Life Technologies, Brown Deer, WI, USA).

2.6. Western Blot

The cells were treated with a lysis buffer supplemented with a protease inhibitor (Solarbio, Beijing, China, Cat. P6730); the total protein was extracted from the cell sample after lysis, which was loaded on 10% SDS-polyacrylamide gel electrophoresis and then transferred onto nitrocellulose filter membranes (Solarbio, Beijing, China, Cat. HATF00010). After the membrane transfer, the membrane was rinsed with PBS and sealed in PBS with 5% skim milk powder for 1 h. Incubating them with primary antibodies, the Ucp3 antibody (1:1000, abclonal, Wuhan, China, Cat. A23285), Myog antibody (1:1000, abclonal, Wuhan, China, Cat. A6664) and Gapdh antibody (1:4000, Proteintech, Wuhan, China, Cat. 60004-1-Ig) were used for a Western blot assay. After washing with TBST, the membranes were incubated with a secondary antibody (1:10,000, LI-COR, Lincoln, NE, USA, Cat. 92632211) at room temperature for 1 h. After the second antibody was incubated, the membranes were exposed using the Odyssey CLX imaging system (LI-COR, Lincoln, NE, USA).

2.7. Statistical Analysis

The two groups of samples were compared using an unpaired Student’s t-test, and multiple groups of samples were analyzed using one-way ANOVA. Data were expressed as “means ± SEM”. A value of p < 0.05 indicated the difference was significant and p < 0.01 represented an extremely significant difference. GraphPad Prism (Version 8, San Diego, CA, USA) was used to conduct the statistical analysis and plotting.

3. Results

3.1. The Expression Patterns of Ucp3

The expression of Ucp3 was detected during the myogenic differentiation of C2C12 cells. The expression of Ucp3 increased from days 1 to 6, with the highest expression at 6 d (Figure 1A). Myog was mainly expressed in the late stage of myogenic differentiation (Figure 1B). The expression patterns of Ucp3 were consistent with that of Myog, suggesting that Ucp3 may play an important role in the myogenic differentiation of C2C12 cells.

3.2. Ucp3 Promoted Myogenic Differentiation of C2C12 Cells

To clarify the function of Ucp3 in myogenic differentiation, the overexpression vector of Ucp3 (OE-Ucp3) was transfected into C2C12 cells using lentivirus. The expression of Ucp3 was significantly increased after transfecting the overexpression vector (Figure 2A). Then, the transfected C2C12 cells were induced to undergo myogenic differentiation. The expressions of Myog and Myhc were upregulated (Figure 2B,D) and the protein levels of Ucp3 and the myogenic factor Myog were dramatically improved in the Ucp3 overexpression group compared with the control group (Figure 2C). Then, the number of Myhc myotubes was increased (Figure 2E,F). In contrast, the mRNA and protein levels of Ucp3 and Myog were significantly reduced in the C2C12 cells transfected with the Ucp3 shRNA vector (Sh-Ucp3) (Figure 3A–C). Also, myogenic factor Myhc was significantly downregulated (Figure 3D) and the number of myotubes decreased with the shRNA of Ucp3 (Figure 3E,F).

3.3. Effects of Ucp3 on Myofiber Conversion

To further determine the regulatory effect of Ucp3 on myofiber types during myogenic differentiation, the overexpression vector of Ucp3 was transfected into C2C12 cells using lentivirus. The expression of Myh7 decreased (Figure 4A) and the number of Myh7-positive cells reduced (Figure 4B,C). Meanwhile, the expression of Myh4 was upregulated (Figure 4D) and the number of Myh4-positive cells increased (Figure 4E,F). In contrast, the expression of Myh7 was upregulated (Figure 5A) and the number of Myh7-positive cells increased (Figure 5B,C) in C2C12 cells transfected with the Ucp3 shRNA vector. The result of Myh4 was the opposite of Myh7 (Figure 5D–F).

3.4. Regulation Effects of Ucp3 on Energy Metabolism in C2C12 Cells

Subsequently, the effects of Ucp3 on energy metabolism were detected. With the Ucp3 overexpression in C2C12 cells, the expression of the glycolysis-related genes (Ldha and Ldhb), oxidative-phosphorylation-related genes (Uqcrc2 and Ndufa9) and mitochondrial-activity-related genes (Pgc1-α and Atp5a1) increased significantly (Figure 6A–C). In contrast, all the above gene expressions decreased due to Ucp3 knockdown (Figure 6D–F).

4. Discussion

Ucp1, Ucp2 and Ucp3 are the members of the Ucp family. Ucp1 is mainly enriched in brown adipose tissue, which is the key protein for nonshivering thermogenesis in mammals. Ucp1 plays an important role in regulating energy metabolism and mitochondrial homeostasis by uncoupling oxidation and phosphorylation, which can consume the energy of the proton gradient in the electron chain to generate heat [13]. Ucp2 is expressed in a variety of tissues, such as white adipose tissue, skeletal muscle, heart, spleen, lung and thymus, which participate in various metabolic processes, including vascular diseases [14], fatty acid metabolism [15], inflammation and oxidative stress [16,17]. Ucp3 is mainly found in skeletal muscle, brown adipose tissue and the myocardium [18,19,20]. Ucp3 plays an important role in regulating energy metabolism, thermogenesis and lipid metabolism in animals. The growth hormone (GH) upregulates the expression of Ucp3 gene, thus increasing the heat production of the body [21]. Kerstin et al. reported that a hamster lacking Ucp3 in brown adipose tissue displays reduced cold tolerance and has impaired nonshivering thermogenesis [22]. Furthermore, Ucp3 expression was significantly increased in the subcutaneous adipose tissue of pigs under cold conditions, and the expressions of beige adipose marker genes (Cd137 and Tmem26) and thermogenesis marker genes (Pgc1-α, Prdm16 and Cidea) were significantly increased, along with the enhancement of mitochondrial activity [7]. Ucp3 is involved in the production of mitochondrial reactive oxygen species (ROS) to prevent mitochondrial oxidative damage [23].
Ucp3 plays an important role in regulating the growth development of skeletal muscle. The expression of Ucp3 in the skeletal muscle of hypothyroidism rats is significantly lower than that of rats with normal thyroid function [24]. Ucp3 is strongly associated with Ca2+ concentration in skeletal muscle. Recent studies highlighted that an intracellular Ca2+ increase can promote the phosphorylation of Camk2, which enhances the Ucp3 expression and fatty acid oxidation [25]. In addition, maternal exercise regulates the content of Ca2+, activating the apelin-AMPK signaling pathway, which promotes the expression of Ucp3 in fetal skeletal muscle [26]. Previous studies showed that miR-181a decreases ATP production in vivo by targeting IGFBP to downregulate the expression of Ucp3 in rat skeletal muscle [27]. At present, there are few reports on the regulation of Ucp3 during the proliferation and differentiation of myoblasts. Gynostemma pentaphyllum extract (GPE) and Gypenoside L (GL) promote the myogenic differentiation of C2C12 cells via activation of the PGC-1α pathway and stimulate the expression of Ucp2 and Ucp3, thus enhancing the anti-oxidative stress ability of the body [28]. Branched-chain amino acid (BCAA) is a key regulator of protein synthesis in skeletal muscle, which promotes the myogenic differentiation of C2C12 cells by activating mTORC1 signaling pathways and significantly increasing the expression of Ucp3 [29]. Furthermore, Yukiko et al. demonstrated that the expression of Ucp3 shows an upward trend during the myoblast differentiation of C2C12 cells, with the highest expression on the eighth day, indicating that Ucp3 may play an important role in the later stage of myoblast differentiation [30]. Our data show that Ucp3 promoted the myoblastic differentiation of C2C12 cells.
Ucp3 plays a key role in controlling energy metabolism in skeletal muscle. Past studies showed that the expression of Ucp3 is elevated in acute exercise and decreased in endurance exercise in skeletal muscle [31]. Compared with normal mice, Ucp3−/− mice show a deficiency in ATP production, oxygen consumption and heat production [32]. Curcumin significantly attenuates myocardial apoptosis in rat cardiomyocytes, and the expression of Ucp3 decreases, indicating that Ucp3 may be involved in curcumin-mediated mitochondrial protection [33]. Additionally, the expression of Ucp3 and Glut4 increases in lanthionine synthase C-like (LANCL1)-overexpressing L6 cells, and oxygen consumption is obviously increased [34]. Insulin-like growth factor-1 (IGF-1) upregulates Ucp3 expression via the phosphorylation of Foxo4, and Ucp3 expression is significantly reduced after the addition of PI3K inhibitors, demonstrating that IGF-1 plays a role in energy homeostasis by regulating Ucp3 expression in C2C12 myoblasts through the PI3-Akt/foxo4 pathway [30]. Moreover, this study showed that Ucp3 contributes to the expression of glycolysis key genes (Ldha, Ldhb), oxidative phosphorylation metabolic genes (Uqcrc2, Ndufa9) and mitochondrial activity marker genes (Pgc1-α, Atp5a1), thereby regulating energy metabolism in C2C12 cells.
The conversion of skeletal muscle fiber types is closely related to energy metabolism. Pgc-1α transgenic pigs increase skeletal muscle mitochondrial biogenesis and ATP synthesis, along with the upregulation of oxidative fiber markers and downregulation of glycolytic fiber markers [35]. Similarly, endurance training in mice enhances skeletal muscle mitochondrial activity through activation of the AMPK signaling pathway, leading to the conversion of type ΙΙb muscle fibers to type Ι muscle fibers [36]. Ucp3 is mainly expressed in type ΙΙb muscle fibers and less so in type Ι muscle fibers [37]. Anguer et al. found that mice overexpressing Ucp3 significantly increase oxygen consumption and oxidize fiber markers after endurance training [38]. In addition, the number of type ΙΙb myofibers in the skeletal muscle of ovariectomized mice increases significantly and the expression of Ucp3 also increases [39]. Moreover, by interfering with the Ucp3 gene in porcine skeletal muscle myoblasts, the activity of Ldh decreases as the expression of type ΙΙb myofiber marker gene Myh4 decreases and the expression of type Ι myofiber marker gene Myh7 increases [40]. The same result was obtained in this study. The expression of the type IIb myofiber marker gene Myh4 was significantly reduced and the number of myotubes was also reduced in C2C12 cells after interfering with Ucp3. Meanwhile, the expression of the type I myofiber marker gene Myh7 was opposite to that of Myh4.
There were some limitations to this study. This study found that Ucp3 could promote myogenic differentiation and accelerate the conversion of myofibers from type Ι to type ΙΙb in C2C12 cells. But, the molecular mechanism of Ucp3 in myogenic differentiation, myotube fusion and energy metabolism is missing. Further research is needed. All experiments in this study were only completed on C2C12 cells. More experiments should be done in other cells, such as mouse, pig, and human primary myoblasts and cell lines. The experimental method was relatively limited in this study. The mRNA expression data and immunofluorescence data presented were insufficient to support the conclusion. The expression of mRNA could only reflect the gene transcription, and could not indicate the amount of protein content. In many cases, the data of mRNA expression and protein content was not consistent because of the post-transcriptional regulation. The immunofluorescence data of protein may not accurately reflect the changes in protein content due to the non-specific immune response. A Western blot experiment can eliminate the band of non-specific immune response through the size of the protein. A Western blot experiment should be done to accurately reflect the changes in protein content. The Western blot experiment successfully obtained the bends of UCP3 and myogenin but failed on Myh4 and Myh7. Therefore, more experiments should be done in further studies.
In my opinion, Ucp3 can promote myotube fusion via the conversion of the mitochondrial inner membrane potential difference into heat in the late stage of the myogenic differentiation of C2C12 cells. Overall, the myogenic differentiation of C2C12 cells requires ATP and heat. PGC1a can enhance cellular respiration and lead to an increase in the mitochondrial inner membrane potential by activating the AMPK and mTOR signaling pathways during the late stage of myogenic differentiation [26,28,29,41]. The high potential of the mitochondrial inner membrane causes ATP synthase to produce ATP while generating heat using Ucp3. Therefore, cellular respiration, mitochondrial activity and Ucp3 content were significantly enhanced during the myogenic differentiation of C2C12 cells. The substrate for cellular respiration is NADH, which is produced via glycolysis and the tricarboxylic acid cycle (TCA cycle) while generating some ATP. Therefore, glycolysis is also significantly enhanced during the myogenic differentiation of C2C12 cells.

5. Conclusions

Ucp3 could promote myogenic differentiation in C2C12 cells and accelerate the conversion of myofibers from type Ι to type ΙΙb. The genes for glycolysis, oxidative phosphorylation and mitochondrial activity increased with Ucp3 overexpression.

Author Contributions

Methodology, F.L.; Software, W.H. and P.G.; Formal analysis, J.W. and M.L.; Data curation, Z.Y.; Writing—original draft, Z.Y.; Writing—review & editing, C.C.; Visualization, Z.Y. and X.G.; Supervision, G.C.; Project administration, G.C. and B.L.; Funding acquisition, C.C. and B.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (grant no. 32272846), the Key Research and Development Project of Shanxi Province (202102140601005), the Special Fund for Science and Technology Innovation Teams of Shanxi Province, the Shanxi Agricultural University Science and Technology Innovation and Promotion Project (CXGC2023014), and the Open Project of the Shanxi Provincial Key Laboratory for Exploration and Precision Breeding of Animal Genetic Resources.

Data Availability Statement

All data generated or analyzed during this study are included.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Qaisar, R.; Renaud, G.; Hedstrom, Y.; Pöllänen, E.; Ronkainen, P.; Kaprio, J.; Alen, M.; Sipilä, S.; Artemenko, K.; Bergquist, J.; et al. Hormone replacement therapy improves contractile function and myonuclear organization of single muscle fibres from postmenopausal monozygotic female twin pairs. J. Physiol. 2013, 591, 2333–2344. [Google Scholar] [CrossRef]
  2. Schiaffino, S.; Reggiani, C. Fiber types in mammalian skeletal muscles. Physiol. Rev. 2011, 91, 1447–1531. [Google Scholar] [CrossRef]
  3. Lefaucheur, L. A second look into fibre typing--relation to meat quality. Meat Sci. 2010, 84, 257–270. [Google Scholar] [CrossRef] [PubMed]
  4. Hwang, Y.H.; Bakhsh, A.; Lee, J.G.; Joo, S.T. Differences in Muscle Fiber Characteristics and Meat Quality by Muscle Type and Age of Korean Native Black Goat. Food Sci. Anim. Resour. 2019, 39, 988–999. [Google Scholar] [CrossRef] [PubMed]
  5. Damon, M.; Vincent, A.; Lombardi, A.; Herpin, P. First evidence of uncoupling protein-2 (UCP-2) and -3 (UCP-3) gene expression in piglet skeletal muscle and adipose tissue. Gene 2000, 246, 133–141. [Google Scholar] [CrossRef]
  6. Millet, L.; Vidal, H.; Andreelli, F.; Larrouy, D.; Riou, J.P.; Ricquier, D.; Laville, M.; Langin, D. Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J. Clin. Investig. 1997, 100, 2665–2670. [Google Scholar] [CrossRef] [PubMed]
  7. Lin, J.; Cao, C.; Tao, C.; Ye, R.; Dong, M.; Zheng, Q.; Wang, C.; Jiang, X.; Qin, G.; Yan, C.; et al. Cold adaptation in pigs depends on UCP3 in beige adipocytes. J. Mol. Cell Biol. 2017, 9, 364–375. [Google Scholar] [CrossRef] [PubMed]
  8. Cai, C.; Qian, L.; Jiang, S.; Sun, Y.; Wang, Q.; Ma, D.; Xiao, G.; Li, B.; Xie, S.; Gao, T.; et al. Loss-of-function myostatin mutation increases insulin sensitivity and browning of white fat in Meishan pigs. Oncotarget 2017, 8, 34911–34922. [Google Scholar] [CrossRef] [PubMed]
  9. Bezaire, V.; Spriet, L.L.; Campbell, S.; Sabet, N.; Gerrits, M.; Bonen, A.; Harper, M.E. Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2005, 19, 977–979. [Google Scholar] [CrossRef]
  10. MacLellan, J.D.; Gerrits, M.F.; Gowing, A.; Smith, P.J.; Wheeler, M.B.; Harper, M.E. Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells. Diabetes 2005, 54, 2343–2350. [Google Scholar] [CrossRef]
  11. Costford, S.R.; Chaudhry, S.N.; Crawford, S.A.; Salkhordeh, M.; Harper, M.E. Long-term high-fat feeding induces greater fat storage in mice lacking UCP3. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E1018–E1024. [Google Scholar] [CrossRef] [PubMed]
  12. Hesselink, M.K.; Keizer, H.A.; Borghouts, L.B.; Schaart, G.; Kornips, C.F.; Slieker, L.J.; Sloop, K.W.; Saris, W.H.; Schrauwen, P. Protein expression of UCP3 differs between human type 1, type 2a, and type 2b fibers. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2001, 15, 1071–1073. [Google Scholar]
  13. Zheng, Q.; Lin, J.; Huang, J.; Zhang, H.; Zhang, R.; Zhang, X.; Cao, C.; Hambly, C.; Qin, G.; Yao, J.; et al. Reconstitution of UCP1 using CRISPR/Cas9 in the white adipose tissue of pigs decreases fat deposition and improves thermogenic capacity. Proc. Natl. Acad. Sci. USA 2017, 114, E9474–E9482. [Google Scholar] [CrossRef] [PubMed]
  14. Pierelli, G.; Stanzione, R.; Forte, M.; Migliarino, S.; Perelli, M.; Volpe, M.; Rubattu, S. Uncoupling Protein 2: A Key Player and a Potential Therapeutic Target in Vascular Diseases. Oxidative Med. Cell. Longev. 2017, 2017, 7348372. [Google Scholar] [CrossRef] [PubMed]
  15. Van Der Lee, K.A.; Willemsen, P.H.; Van Der Vusse, G.J.; Van Bilsen, M. Effects of fatty acids on uncoupling protein-2 expression in the rat heart. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2000, 14, 495–502. [Google Scholar] [CrossRef]
  16. Ding, Y.; Zheng, Y.; Huang, J.; Peng, W.; Chen, X.; Kang, X.; Zeng, Q. UCP2 ameliorates mitochondrial dysfunction, inflammation, and oxidative stress in lipopolysaccharide-induced acute kidney injury. Int. Immunopharmacol. 2019, 71, 336–349. [Google Scholar] [CrossRef]
  17. Kim, D.H.; Kim, H.J.; Seong, J.K. UCP2 KO mice exhibit ameliorated obesity and inflammation induced by high-fat diet feeding. BMB Rep. 2022, 55, 500–505. [Google Scholar] [CrossRef]
  18. Boss, O.; Samec, S.; Paoloni-Giacobino, A.; Rossier, C.; Dulloo, A.; Seydoux, J.; Muzzin, P.; Giacobino, J.P. Uncoupling protein-3: A new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 1997, 408, 39–42. [Google Scholar] [CrossRef]
  19. Vidal-Puig, A.; Solanes, G.; Grujic, D.; Flier, J.S.; Lowell, B.B. UCP3: An uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem. Biophys. Res. Commun. 1997, 235, 79–82. [Google Scholar] [CrossRef]
  20. Razeghi, P.; Young, M.E.; Ying, J.; Depre, C.; Uray, I.P.; Kolesar, J.; Shipley, G.L.; Moravec, C.S.; Davies, P.J.; Frazier, O.H.; et al. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 2002, 97, 203–209. [Google Scholar] [CrossRef]
  21. Hayashi, M.; Futawaka, K.; Matsushita, M.; Koyama, R.; Fun, Y.; Fukuda, Y.; Nushida, A.; Nezu, S.; Tagami, T.; Moriyama, K. GH directly stimulates UCP3 expression. Growth Horm. IGF Res. 2018, 40, 44–54. [Google Scholar] [CrossRef]
  22. Nau, K.; Fromme, T.; Meyer, C.W.; von Praun, C.; Heldmaier, G.; Klingenspor, M. Brown adipose tissue specific lack of uncoupling protein 3 is associated with impaired cold tolerance and reduced transcript levels of metabolic genes. J. Comp. Physiol. B Biochem. Syst. Environ. Physiol. 2008, 178, 269–277. [Google Scholar] [CrossRef]
  23. Cadenas, S. Mitochondrial uncoupling, ROS generation and cardioprotection. Biochim. Biophys. Acta. Bioenerg. 2018, 1859, 940–950. [Google Scholar] [CrossRef]
  24. Lanni, A.; Beneduce, L.; Lombardi, A.; Moreno, M.; Boss, O.; Muzzin, P.; Giacobino, J.P.; Goglia, F. Expression of uncoupling protein-3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle. FEBS Lett. 1999, 444, 250–254. [Google Scholar] [CrossRef] [PubMed]
  25. Costford, S.R.; Seifert, E.L.; Bézaire, V.; Gerrits, M.F.; Bevilacqua, L.; Gowing, A.; Harper, M.E. The energetic implications of uncoupling protein-3 in skeletal muscle. Appl. Physiol. Nutr. Metab. 2007, 32, 884–894. [Google Scholar] [CrossRef]
  26. Son, J.S.; Chae, S.A.; Zhao, L.; Wang, H.; de Avila, J.M.; Zhu, M.J.; Jiang, Z.; Du, M. Maternal exercise intergenerationally drives muscle-based thermogenesis via activation of apelin-AMPK signaling. EBioMedicine 2022, 76, 103842. [Google Scholar] [CrossRef] [PubMed]
  27. Zhao, K.; Li, X.; Zhang, M.; Tong, F.; Chen, H.; Wang, X.; Xiu, N.; Liu, Z.; Wang, Y. microRNA-181a Promotes Mitochondrial Dysfunction and Inflammatory Reaction in a Rat Model of Intensive Care Unit-Acquired Weakness by Inhibiting IGFBP5 Expression. J. Neuropathol. Exp. Neurol. 2022, 81, 553–564. [Google Scholar] [CrossRef] [PubMed]
  28. Kim, Y.H.; Jung, J.I.; Jeon, Y.E.; Kim, S.M.; Oh, T.K.; Lee, J.; Moon, J.M.; Kim, T.Y.; Kim, E.J. Gynostemma pentaphyllum extract and Gypenoside L enhance skeletal muscle differentiation and mitochondrial metabolism by activating the PGC-1α pathway in C2C12 myotubes. Nutr. Res. Pract. 2022, 16, 14–32. [Google Scholar] [CrossRef]
  29. Duan, Y.; Zeng, L.; Li, F.; Wang, W.; Li, Y.; Guo, Q.; Ji, Y.; Tan, B.; Yin, Y. Effect of branched-chain amino acid ratio on the proliferation, differentiation, and expression levels of key regulators involved in protein metabolism of myocytes. Nutrition 2017, 36, 8–16. [Google Scholar] [CrossRef]
  30. Watamoto, Y.; Futawaka, K.; Hayashi, M.; Matsushita, M.; Mitsutani, M.; Murakami, K.; Song, Z.; Koyama, R.; Fukuda, Y.; Nushida, A.; et al. Insulin-like growth factor-1 directly mediates expression of mitochondrial uncoupling protein 3 via forkhead box O4. Growth Horm. IGF Res. 2019, 46–47, 24–35. [Google Scholar] [CrossRef]
  31. Schrauwen, P.; Hesselink, M. Uncoupling protein 3 and physical activity: The role of uncoupling protein 3 in energy metabolism revisited. Proc. Nutr. Soc. 2003, 62, 635–643. [Google Scholar] [CrossRef] [PubMed]
  32. Lang, H.; Xiang, Y.; Ai, Z.; You, Z.; Jin, X.; Wan, Y.; Yang, Y. UCP3 Ablation Exacerbates High-Salt Induced Cardiac Hypertrophy and Cardiac Dysfunction. Cell. Physiol. Biochem. 2018, 46, 1683–1692. [Google Scholar] [CrossRef]
  33. Zhang, J.; Liu, S.; Jiang, L.; Hou, J.; Yang, Z. Curcumin Improves Cardiopulmonary Resuscitation Outcomes by Modulating Mitochondrial Metabolism and Apoptosis in a Rat Model of Cardiac Arrest. Front. Cardiovasc. Med. 2022, 9, 908755. [Google Scholar] [CrossRef] [PubMed]
  34. Spinelli, S.; Begani, G.; Guida, L.; Magnone, M.; Galante, D.; D’Arrigo, C.; Scotti, C.; Iamele, L.; De Jonge, H.; Zocchi, E.; et al. LANCL1 binds abscisic acid and stimulates glucose transport and mitochondrial respiration in muscle cells via the AMPK/PGC-1α/Sirt1 pathway. Mol. Metab. 2021, 53, 101263. [Google Scholar] [CrossRef]
  35. Zhang, L.; Zhou, Y.; Wu, W.; Hou, L.; Chen, H.; Zuo, B.; Xiong, Y.; Yang, J. Skeletal Muscle-Specific Overexpression of PGC-1α Induces Fiber-Type Conversion through Enhanced Mitochondrial Respiration and Fatty Acid Oxidation in Mice and Pigs. Int. J. Biol. Sci. 2017, 13, 1152–1162. [Google Scholar] [CrossRef] [PubMed]
  36. Lantier, L.; Fentz, J.; Mounier, R.; Leclerc, J.; Treebak, J.T.; Pehmøller, C.; Sanz, N.; Sakakibara, I.; Saint-Amand, E.; Rimbaud, S.; et al. AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2014, 28, 3211–3224. [Google Scholar] [CrossRef]
  37. Schrauwen, P.; Hoeks, J.; Hesselink, M.K. Putative function and physiological relevance of the mitochondrial uncoupling protein-3: Involvement in fatty acid metabolism? Prog. Lipid Res. 2006, 45, 17–41. [Google Scholar] [CrossRef]
  38. Aguer, C.; Fiehn, O.; Seifert, E.L.; Bézaire, V.; Meissen, J.K.; Daniels, A.; Scott, K.; Renaud, J.M.; Padilla, M.; Bickel, D.R.; et al. Muscle uncoupling protein 3 overexpression mimics endurance training and reduces circulating biomarkers of incomplete β-oxidation. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2013, 27, 4213–4225. [Google Scholar] [CrossRef]
  39. Nagai, S.; Ikeda, K.; Horie-Inoue, K.; Shiba, S.; Nagasawa, S.; Takeda, S.; Inoue, S. Estrogen modulates exercise endurance along with mitochondrial uncoupling protein 3 downregulation in skeletal muscle of female mice. Biochem. Biophys. Res. Commun. 2016, 480, 758–764. [Google Scholar] [CrossRef]
  40. Zhang, Y.; Yan, H.; Zhou, P.; Zhang, Z.; Liu, J.; Zhang, H. MicroRNA-152 Promotes Slow-Twitch Myofiber Formation via Targeting Uncoupling Protein-3 Gene. Anim. Open Access J. MDPI 2019, 9, 669. [Google Scholar] [CrossRef]
  41. Lima, T.I.; Guimarães, D.; Sponton, C.H.; Bajgelman, M.C.; Palameta, S.; Toscaro, J.M.; Reis, O.; Silveira, L.R. Essential role of the PGC-1α/PPARβ axis in Ucp3 gene induction. J. Physiol. 2019, 597, 4277–4291. [Google Scholar] [CrossRef] [PubMed]
Genes 14 02049 g001
Figure 1. Expression characteristics of Ucp3 in myogenic differentiation of C2C12 cells. (A,B) Timecourse of Ucp3 and Myog mRNA expression during myogenic differentiation of C2C12 cells. C2C12 cells were differentiated into myoblasts using DMEM, 2% horse serum and 1% double antibody. Bar graphs with the same superscript letters indicate no significant difference (p > 0.05), while those with different superscript letters indicate significant differences (p < 0.05).
Figure 1. Expression characteristics of Ucp3 in myogenic differentiation of C2C12 cells. (A,B) Timecourse of Ucp3 and Myog mRNA expression during myogenic differentiation of C2C12 cells. C2C12 cells were differentiated into myoblasts using DMEM, 2% horse serum and 1% double antibody. Bar graphs with the same superscript letters indicate no significant difference (p > 0.05), while those with different superscript letters indicate significant differences (p < 0.05).
Genes 14 02049 g001
Genes 14 02049 g002
Figure 2. Ucp3 overexpression promotes myogenic differentiation in C2C12 cells. (A) qRT–PCR was used to test the Ucp3 overexpression efficiency in C2C12 cells. (B) The expression of Myog gene after affecting the Ucp3 overexpression. (C) Expression changes of Ucp3 and myogenic factor Myog at protein level. (D) Expression changes in Myhc gene after overexpression of Ucp3, as determined using qRT–PCR. (E,F) Myotube formation was detected using immunofluorescence and quantified positive cell statistics. **: p < 0.01.
Figure 2. Ucp3 overexpression promotes myogenic differentiation in C2C12 cells. (A) qRT–PCR was used to test the Ucp3 overexpression efficiency in C2C12 cells. (B) The expression of Myog gene after affecting the Ucp3 overexpression. (C) Expression changes of Ucp3 and myogenic factor Myog at protein level. (D) Expression changes in Myhc gene after overexpression of Ucp3, as determined using qRT–PCR. (E,F) Myotube formation was detected using immunofluorescence and quantified positive cell statistics. **: p < 0.01.
Genes 14 02049 g002
Genes 14 02049 g003
Figure 3. Ucp3 silencing slowed myogenesis of C2C12 cells. (A) Expression level of Ucp3 was determined using qRT–PCR following shRNA knockdown. (B) mRNA levels of Myog knockdown, as detected using qRT–PCR. (C) Western blot was used to test Ucp3 and myogenic factor Myog. (D) The level of Myhc mRNA after knockdown of Ucp3. (E,F) Myotube formation was detected using immunofluorescence and quantified positive cell statistics. **: p < 0.01.
Figure 3. Ucp3 silencing slowed myogenesis of C2C12 cells. (A) Expression level of Ucp3 was determined using qRT–PCR following shRNA knockdown. (B) mRNA levels of Myog knockdown, as detected using qRT–PCR. (C) Western blot was used to test Ucp3 and myogenic factor Myog. (D) The level of Myhc mRNA after knockdown of Ucp3. (E,F) Myotube formation was detected using immunofluorescence and quantified positive cell statistics. **: p < 0.01.
Genes 14 02049 g003
Genes 14 02049 g004
Figure 4. Active Ucp3 could motivate the muscle-fiber-type transformation from type I to IIb. (A) qRT–PCR was used to test the expression of oxidized muscle fiber marker gene Myh7. (B,C) Immunofluorescence staining was used to identify the positive signal of Myh7. (D) The level of colytic muscle fiber marker gene Myh4 in C2C12 cells. (E,F) Immunofluorescence staining was used to identify the positive signal of Myh4. *: p < 0.05, **: p < 0.01.
Figure 4. Active Ucp3 could motivate the muscle-fiber-type transformation from type I to IIb. (A) qRT–PCR was used to test the expression of oxidized muscle fiber marker gene Myh7. (B,C) Immunofluorescence staining was used to identify the positive signal of Myh7. (D) The level of colytic muscle fiber marker gene Myh4 in C2C12 cells. (E,F) Immunofluorescence staining was used to identify the positive signal of Myh4. *: p < 0.05, **: p < 0.01.
Genes 14 02049 g004
Genes 14 02049 g005
Figure 5. Ucp3 knockdown increased the muscle-fiber-type transformation from type IIb to I. (A) Expression changes of the oxidized muscle fiber marker gene Myh7 were determined using qRT–PCR following inhibitor of Ucp3. (B,C) Myotube formation was detected using immunofluorescence under the same conditions and quantified using positive cell statistics. (D) Expression changes of the colytic muscle fiber marker gene Myh4 using qRT–PCR, as specified in the legend. (E,F) Positive signal identification assay carried out in the same way as in panel. *: p < 0.05, **: p < 0.01.
Figure 5. Ucp3 knockdown increased the muscle-fiber-type transformation from type IIb to I. (A) Expression changes of the oxidized muscle fiber marker gene Myh7 were determined using qRT–PCR following inhibitor of Ucp3. (B,C) Myotube formation was detected using immunofluorescence under the same conditions and quantified using positive cell statistics. (D) Expression changes of the colytic muscle fiber marker gene Myh4 using qRT–PCR, as specified in the legend. (E,F) Positive signal identification assay carried out in the same way as in panel. *: p < 0.05, **: p < 0.01.
Genes 14 02049 g005
Genes 14 02049 g006
Figure 6. Ucp3 had a positive regulatory effect on energy metabolism in C2C12 cells. (A–C) Relative levels of genes associated with energy metabolism due to overexpression of Ucp3 in C2C12 cells. (D–F) Quantitative real-time PCR analysis of gene expression levels associated with energy metabolism by silencing Ucp3 gene. *: p < 0.05, **: p < 0.01.
Figure 6. Ucp3 had a positive regulatory effect on energy metabolism in C2C12 cells. (A–C) Relative levels of genes associated with energy metabolism due to overexpression of Ucp3 in C2C12 cells. (D–F) Quantitative real-time PCR analysis of gene expression levels associated with energy metabolism by silencing Ucp3 gene. *: p < 0.05, **: p < 0.01.
Genes 14 02049 g006
Table 1. Primer sequences.
Table 1. Primer sequences.
GenePrimer Sequences (5′–3′)
Ucp3F: GCCGGCACTGCGGCCTGTTTT
R: TGTGCGCACCATAGTCAGGAT
MyogF: TCCCAACCCAGGAGATCATT
R: AGTTGGGCATGGTTTCGTCT
MyhcF: ACTTGTGGTGTCGGTCACTC
R: CTGAAAATCAGCCGCACGTC
Myh4F: CTCACCTACCAGACCGAGGA
R: CTCCTGTCACCTCTCAACAGA
Myh7F: GATTCCTCTAGGACAGCAGCG
R: TTCCTTTCTCTGAGCCACCTTG
Pgc1-αF: TGTGTGCTGTGTGTCAGAGT
R: ACCAGAGCAGCACACTCTAT
Atp5a1F: TTGTTGGTGCAAGAAATCTCCA
R: TACCATCACCAATGCTTAACACA
LdhaF: AACTTGGCGCTCTACTTGCT
R: GGACTTTGAATCTTTTGAGACCTTG
LdhbF: AAAGGCTACACCAACTGGGC
R: GCCGTACATTCCCTTCACCA
Uqcrc2F: CCGGGTCCTTCTCGAGATTTT
R: TGCTTCAATCCCACGGGTTA
Ndufa9F: TTCCAATGTCACGTCCTGCC
R: CTTGTGACCCCATTCGTCCA
18S rRNAF: ATAAACGATGCCGACTGGCGAT
R: CAATCTGTCAATCCTGTCCGTGT
F: forward; R: reverse.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

You, Z.; Wang, J.; Li, F.; Hei, W.; Li, M.; Guo, X.; Gao, P.; Cao, G.; Cai, C.; Li, B. Uncoupling Protein 3 Promotes the Myogenic Differentiation of Type IIb Myotubes in C2C12 Cells. Genes 2023, 14, 2049. https://doi.org/10.3390/genes14112049

AMA Style

You Z, Wang J, Li F, Hei W, Li M, Guo X, Gao P, Cao G, Cai C, Li B. Uncoupling Protein 3 Promotes the Myogenic Differentiation of Type IIb Myotubes in C2C12 Cells. Genes. 2023; 14(11):2049. https://doi.org/10.3390/genes14112049

Chicago/Turabian Style

You, Ziwei, Jieyu Wang, Faliang Li, Wei Hei, Meng Li, Xiaohong Guo, Pengfei Gao, Guoqing Cao, Chunbo Cai, and Bugao Li. 2023. "Uncoupling Protein 3 Promotes the Myogenic Differentiation of Type IIb Myotubes in C2C12 Cells" Genes 14, no. 11: 2049. https://doi.org/10.3390/genes14112049

APA Style

You, Z., Wang, J., Li, F., Hei, W., Li, M., Guo, X., Gao, P., Cao, G., Cai, C., & Li, B. (2023). Uncoupling Protein 3 Promotes the Myogenic Differentiation of Type IIb Myotubes in C2C12 Cells. Genes, 14(11), 2049. https://doi.org/10.3390/genes14112049

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop